Recruiting

Rehabilitation Technology

Sponsor:

Rehabilitation Hospital of Overland Park

Code:

NCT05652946

Conditions

Neurologic Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics

Standard inpatient rehabilitation therapy

Study Details

Brief summary:

A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation. We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.

Conditions

Neurologic Disorder

Study ID

NCT05652946

Start date

Oct 17, 2022

Status verified date

Dec, 2022

Completion date

Jan 17, 2025

Anticipated

Primary completion date

Oct 17, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Currently admitted for inpatient rehabilitation at Rehabilitation Hospital Overland Park with neurological diagnosis.
2. At least 18 years of age.
3. Predicted length of stay to be at least 7 days.
4. Able to tolerate upright sitting without orthostatic hypotension for upper extremity, cycling, and sitting balance devices AND/OR able to tolerate upright standing for at least 15 minutes without orthostatic hypotension for walking and standing balance devices.
5. Able to fit into at least one device.
6. Screened and cleared by a physician.
7. Cognitively intact to communicate pain and/or need to stop session, and able to follow simple commands.

Exclusion Criteria:

1. Current or history of other medical conditions that could affect the outcome measures.
2. Currently involved in another intervention study.
3. Any absolute contraindication listed for each device used.
4. Any pre-existing physical or medical condition that the Physiatrist determines would significantly limit a patient's ability to benefit from or continue in the study.

Study Design

Enrollment

200 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Inpatient Rehabilitation with ART

Inpatient rehabilitation with advanced rehabilitation technology

active comparator: Inpatient Rehabilitation without ART

Inpatient rehabilitation without advanced rehabilitation technology

Interventions

Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics

Participants to receive at least 5 sessions with advanced rehabilitation technology including at least one, or multiple, of the following devices: Amadeo, Diego, Myro, Arm Motus EMU, Pelma Motus, Tigo, Balo, EKSO NR. Sessions are 45 (+/- 5) minutes

Standard inpatient rehabilitation therapy

Standard inpatient rehabilitation therapy without advanced rehabilitation technology

Primary outcome measure

  • Neuro-QOL [ Time Frame: Through study completion, an average of 2 years ]

Central Contacts and Locations

Central contacts

Locations

Rehabilitation Hospital of Overland Park

Recruiting

Overland Park, Kansas, United States, 66207

More Information

Sponsor

Rehabilitation Hospital of Overland Park

Last update posted

Dec 15, 2022

Last verified

Dec, 2022

Keywords

  • Advanced Rehabilitation Technology
  • Therapeutic Device
  • Robotic Rehabilitation Research
  • Health Economics
  • Functional Outcomes

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rehabilitation Hospital of Overland Park on 2022-12-15.